BGI
The Chinese sequencing instrument maker, affiliated with BGI Group, plans to roll out a plethora of platforms in the US next year, targeting various market needs.
BGI Group Vows to Sue Ex-Business Partner for Defamation
BGI Group said it will take legal action against Deming Wang, who has repeatedly alleged BGI Genomics’ PCR tests are inaccurate, causing the firm's stock to drop.
In Brief This Week: Biocept, Thermo Fisher, Biodesix, More
News items for the week of Nov. 21, 2022.
In Brief This Week: Pacific Biosciences, Pierian, PerkinElmer, Ginkgo Bioworks, More
News items for the week of Oct. 17, 2022.
The Chinese sequencing tech company also reported a net profit of RMB 1.68 billion for the quarter, driven by a recent settlement payment from Illumina.
Sep 27, 2022
Sep 2, 2022
BGI Gets CE-IVD Mark for Thalassemia Test
Aug 29, 2022
MGI Tech Planning to go Public in $366M Chinese IPO
Jun 13, 2022
Jun 10, 2022
Jun 6, 2022
May 5, 2022